 | • レポートコード：MRC23Q35824 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の生物工学による代用皮膚市場について調査・分析し、世界の生物工学による代用皮膚市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（同種無細胞、異種、同種細胞、自家細胞）、用途別セグメント分析（病院、専門クリニック、創傷治療センター）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Allergan (AbbVie)、AlloSource、Organogenesis、BD、Smith & Nephew、Integra LifeSciences、Synthes (Johnson & Johnson)、Axogen、Vericel Corporation、LifeNet Health、MTF Biologics、Arthrex、Wright Medical Group NV (Stryker)、Cook Biotech Incorporated、Aroa Biosurgery、Surgalign Holdings、Anika Therapeutics、Forticell Bioscience、MLM Biologics、Promethean LifeSciencesなどが含まれています。 世界の生物工学による代用皮膚市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、生物工学による代用皮膚市場規模を推定する際に考慮しました。本レポートは、生物工学による代用皮膚の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、生物工学による代用皮膚に関するビジネス上の意思決定に役立てることを目的としています。 ・生物工学による代用皮膚市場の概要 - 生物工学による代用皮膚のタイプ別セグメント - 世界の生物工学による代用皮膚市場規模：タイプ別分析（同種無細胞、異種、同種細胞、自家細胞） - 生物工学による代用皮膚の用途別セグメント - 世界の生物工学による代用皮膚市場規模：用途別分析（病院、専門クリニック、創傷治療センター） - 世界の生物工学による代用皮膚市場規模予測（2018年-2029年） ・生物工学による代用皮膚市場の成長トレンド - 生物工学による代用皮膚の地域別市場規模（2018年-2029年） - 生物工学による代用皮膚市場ダイナミクス - 生物工学による代用皮膚の業界動向 - 生物工学による代用皮膚市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：同種無細胞、異種、同種細胞、自家細胞 - 世界の生物工学による代用皮膚のタイプ別市場規模（2018年-2023年） - 世界の生物工学による代用皮膚のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、専門クリニック、創傷治療センター - 世界の生物工学による代用皮膚の用途別市場規模（2018年-2023年） - 世界の生物工学による代用皮膚の用途別市場規模（2024年-2029年） ・生物工学による代用皮膚の地域別市場規模 - 北米の生物工学による代用皮膚市場規模（2018年-2029年） - アメリカの生物工学による代用皮膚市場規模（2018年-2029年） - ヨーロッパの生物工学による代用皮膚市場規模（2018年-2029年） - アジア太平洋の生物工学による代用皮膚市場規模（2018年-2029年） - 中国の生物工学による代用皮膚市場規模（2018年-2029年） - 日本の生物工学による代用皮膚市場規模（2018年-2029年） - 韓国の生物工学による代用皮膚市場規模（2018年-2029年） - インドの生物工学による代用皮膚市場規模（2018年-2029年） - オーストラリアの生物工学による代用皮膚市場規模（2018年-2029年） - 中南米の生物工学による代用皮膚市場規模（2018年-2029年） - 中東・アフリカの生物工学による代用皮膚市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Allergan (AbbVie)、AlloSource、Organogenesis、BD、Smith & Nephew、Integra LifeSciences、Synthes (Johnson & Johnson)、Axogen、Vericel Corporation、LifeNet Health、MTF Biologics、Arthrex、Wright Medical Group NV (Stryker)、Cook Biotech Incorporated、Aroa Biosurgery、Surgalign Holdings、Anika Therapeutics、Forticell Bioscience、MLM Biologics、Promethean LifeSciences ・アナリストの観点/結論 ・調査方法とデータソース |
Bioengineered skin consists of the outer epidermis and/or dermis (the layer of skin between the epidermis and subcutaneous tissue) embedded in an acellular matrix (supporting structure) to form a biological skin substitute. Products are made from a variety of sources, including human tissue (from patients or others), non-human tissue (bovine, porcine, horse), synthetic materials (man-made), or a combination of these materials.
Highlights
The global Bioengineered Skin Substitutes market was valued at US$ 1717.4 million in 2022 and is anticipated to reach US$ 3355.4 million by 2029, witnessing a CAGR of 11.8% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global important companies in bioengineered skin substitutes includes Allergan (AbbVie), AlloSource, Organogenesis, and BD. The head company shares over 30% of the market. Geographically speaking, Americas holds about 50% of global market share, followed by Europe with about 35% share. Bioengineered skin substitutes includes Allogeneic Acellular, Xenogeneic, Allogeneic Cells, and Autologous. Allogeneic Acellular is the largest part of bioengineered skin substitutes industry, has a share about 80%. Other key parts include Xenogeneic who shares nearly 15% , and Autologous who shares about 5%. The application of bioengineered skin substitutes includes hospitals,specialty clinics and wound care centers. Hospitals shares the largest percent of 60.30%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bioengineered Skin Substitutes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioengineered Skin Substitutes.
The Bioengineered Skin Substitutes market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Bioengineered Skin Substitutes market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bioengineered Skin Substitutes companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Allergan (AbbVie)
AlloSource
Organogenesis
BD
Smith & Nephew
Integra LifeSciences
Synthes (Johnson & Johnson)
Axogen
Vericel Corporation
LifeNet Health
MTF Biologics
Arthrex
Wright Medical Group NV (Stryker)
Cook Biotech Incorporated
Aroa Biosurgery
Surgalign Holdings
Anika Therapeutics
Forticell Bioscience
MLM Biologics
Promethean LifeSciences
Segment by Type
Allogeneic Acellular
Xenogeneic
Allogeneic Cells
Autologous
Segment by Application
Hospitals
Specialty Clinics
Wound Care Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bioengineered Skin Substitutes companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bioengineered Skin Substitutes Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Allogeneic Acellular
1.2.3 Xenogeneic
1.2.4 Allogeneic Cells
1.2.5 Autologous
1.3 Market by Application
1.3.1 Global Bioengineered Skin Substitutes Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Wound Care Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bioengineered Skin Substitutes Market Perspective (2018-2029)
2.2 Bioengineered Skin Substitutes Growth Trends by Region
2.2.1 Global Bioengineered Skin Substitutes Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Bioengineered Skin Substitutes Historic Market Size by Region (2018-2023)
2.2.3 Bioengineered Skin Substitutes Forecasted Market Size by Region (2024-2029)
2.3 Bioengineered Skin Substitutes Market Dynamics
2.3.1 Bioengineered Skin Substitutes Industry Trends
2.3.2 Bioengineered Skin Substitutes Market Drivers
2.3.3 Bioengineered Skin Substitutes Market Challenges
2.3.4 Bioengineered Skin Substitutes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bioengineered Skin Substitutes Players by Revenue
3.1.1 Global Top Bioengineered Skin Substitutes Players by Revenue (2018-2023)
3.1.2 Global Bioengineered Skin Substitutes Revenue Market Share by Players (2018-2023)
3.2 Global Bioengineered Skin Substitutes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bioengineered Skin Substitutes Revenue
3.4 Global Bioengineered Skin Substitutes Market Concentration Ratio
3.4.1 Global Bioengineered Skin Substitutes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bioengineered Skin Substitutes Revenue in 2022
3.5 Bioengineered Skin Substitutes Key Players Head office and Area Served
3.6 Key Players Bioengineered Skin Substitutes Product Solution and Service
3.7 Date of Enter into Bioengineered Skin Substitutes Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bioengineered Skin Substitutes Breakdown Data by Type
4.1 Global Bioengineered Skin Substitutes Historic Market Size by Type (2018-2023)
4.2 Global Bioengineered Skin Substitutes Forecasted Market Size by Type (2024-2029)
5 Bioengineered Skin Substitutes Breakdown Data by Application
5.1 Global Bioengineered Skin Substitutes Historic Market Size by Application (2018-2023)
5.2 Global Bioengineered Skin Substitutes Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Bioengineered Skin Substitutes Market Size (2018-2029)
6.2 North America Bioengineered Skin Substitutes Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Bioengineered Skin Substitutes Market Size by Country (2018-2023)
6.4 North America Bioengineered Skin Substitutes Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bioengineered Skin Substitutes Market Size (2018-2029)
7.2 Europe Bioengineered Skin Substitutes Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Bioengineered Skin Substitutes Market Size by Country (2018-2023)
7.4 Europe Bioengineered Skin Substitutes Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bioengineered Skin Substitutes Market Size (2018-2029)
8.2 Asia-Pacific Bioengineered Skin Substitutes Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Bioengineered Skin Substitutes Market Size by Region (2018-2023)
8.4 Asia-Pacific Bioengineered Skin Substitutes Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bioengineered Skin Substitutes Market Size (2018-2029)
9.2 Latin America Bioengineered Skin Substitutes Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Bioengineered Skin Substitutes Market Size by Country (2018-2023)
9.4 Latin America Bioengineered Skin Substitutes Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bioengineered Skin Substitutes Market Size (2018-2029)
10.2 Middle East & Africa Bioengineered Skin Substitutes Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Bioengineered Skin Substitutes Market Size by Country (2018-2023)
10.4 Middle East & Africa Bioengineered Skin Substitutes Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan (AbbVie)
11.1.1 Allergan (AbbVie) Company Detail
11.1.2 Allergan (AbbVie) Business Overview
11.1.3 Allergan (AbbVie) Bioengineered Skin Substitutes Introduction
11.1.4 Allergan (AbbVie) Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.1.5 Allergan (AbbVie) Recent Development
11.2 AlloSource
11.2.1 AlloSource Company Detail
11.2.2 AlloSource Business Overview
11.2.3 AlloSource Bioengineered Skin Substitutes Introduction
11.2.4 AlloSource Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.2.5 AlloSource Recent Development
11.3 Organogenesis
11.3.1 Organogenesis Company Detail
11.3.2 Organogenesis Business Overview
11.3.3 Organogenesis Bioengineered Skin Substitutes Introduction
11.3.4 Organogenesis Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.3.5 Organogenesis Recent Development
11.4 BD
11.4.1 BD Company Detail
11.4.2 BD Business Overview
11.4.3 BD Bioengineered Skin Substitutes Introduction
11.4.4 BD Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.4.5 BD Recent Development
11.5 Smith & Nephew
11.5.1 Smith & Nephew Company Detail
11.5.2 Smith & Nephew Business Overview
11.5.3 Smith & Nephew Bioengineered Skin Substitutes Introduction
11.5.4 Smith & Nephew Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.5.5 Smith & Nephew Recent Development
11.6 Integra LifeSciences
11.6.1 Integra LifeSciences Company Detail
11.6.2 Integra LifeSciences Business Overview
11.6.3 Integra LifeSciences Bioengineered Skin Substitutes Introduction
11.6.4 Integra LifeSciences Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.6.5 Integra LifeSciences Recent Development
11.7 Synthes (Johnson & Johnson)
11.7.1 Synthes (Johnson & Johnson) Company Detail
11.7.2 Synthes (Johnson & Johnson) Business Overview
11.7.3 Synthes (Johnson & Johnson) Bioengineered Skin Substitutes Introduction
11.7.4 Synthes (Johnson & Johnson) Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.7.5 Synthes (Johnson & Johnson) Recent Development
11.8 Axogen
11.8.1 Axogen Company Detail
11.8.2 Axogen Business Overview
11.8.3 Axogen Bioengineered Skin Substitutes Introduction
11.8.4 Axogen Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.8.5 Axogen Recent Development
11.9 Vericel Corporation
11.9.1 Vericel Corporation Company Detail
11.9.2 Vericel Corporation Business Overview
11.9.3 Vericel Corporation Bioengineered Skin Substitutes Introduction
11.9.4 Vericel Corporation Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.9.5 Vericel Corporation Recent Development
11.10 LifeNet Health
11.10.1 LifeNet Health Company Detail
11.10.2 LifeNet Health Business Overview
11.10.3 LifeNet Health Bioengineered Skin Substitutes Introduction
11.10.4 LifeNet Health Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.10.5 LifeNet Health Recent Development
11.11 MTF Biologics
11.11.1 MTF Biologics Company Detail
11.11.2 MTF Biologics Business Overview
11.11.3 MTF Biologics Bioengineered Skin Substitutes Introduction
11.11.4 MTF Biologics Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.11.5 MTF Biologics Recent Development
11.12 Arthrex
11.12.1 Arthrex Company Detail
11.12.2 Arthrex Business Overview
11.12.3 Arthrex Bioengineered Skin Substitutes Introduction
11.12.4 Arthrex Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.12.5 Arthrex Recent Development
11.13 Wright Medical Group NV (Stryker)
11.13.1 Wright Medical Group NV (Stryker) Company Detail
11.13.2 Wright Medical Group NV (Stryker) Business Overview
11.13.3 Wright Medical Group NV (Stryker) Bioengineered Skin Substitutes Introduction
11.13.4 Wright Medical Group NV (Stryker) Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.13.5 Wright Medical Group NV (Stryker) Recent Development
11.14 Cook Biotech Incorporated
11.14.1 Cook Biotech Incorporated Company Detail
11.14.2 Cook Biotech Incorporated Business Overview
11.14.3 Cook Biotech Incorporated Bioengineered Skin Substitutes Introduction
11.14.4 Cook Biotech Incorporated Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.14.5 Cook Biotech Incorporated Recent Development
11.15 Aroa Biosurgery
11.15.1 Aroa Biosurgery Company Detail
11.15.2 Aroa Biosurgery Business Overview
11.15.3 Aroa Biosurgery Bioengineered Skin Substitutes Introduction
11.15.4 Aroa Biosurgery Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.15.5 Aroa Biosurgery Recent Development
11.16 Surgalign Holdings
11.16.1 Surgalign Holdings Company Detail
11.16.2 Surgalign Holdings Business Overview
11.16.3 Surgalign Holdings Bioengineered Skin Substitutes Introduction
11.16.4 Surgalign Holdings Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.16.5 Surgalign Holdings Recent Development
11.17 Anika Therapeutics
11.17.1 Anika Therapeutics Company Detail
11.17.2 Anika Therapeutics Business Overview
11.17.3 Anika Therapeutics Bioengineered Skin Substitutes Introduction
11.17.4 Anika Therapeutics Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.17.5 Anika Therapeutics Recent Development
11.18 Forticell Bioscience
11.18.1 Forticell Bioscience Company Detail
11.18.2 Forticell Bioscience Business Overview
11.18.3 Forticell Bioscience Bioengineered Skin Substitutes Introduction
11.18.4 Forticell Bioscience Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.18.5 Forticell Bioscience Recent Development
11.19 MLM Biologics
11.19.1 MLM Biologics Company Detail
11.19.2 MLM Biologics Business Overview
11.19.3 MLM Biologics Bioengineered Skin Substitutes Introduction
11.19.4 MLM Biologics Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.19.5 MLM Biologics Recent Development
11.20 Promethean LifeSciences
11.20.1 Promethean LifeSciences Company Detail
11.20.2 Promethean LifeSciences Business Overview
11.20.3 Promethean LifeSciences Bioengineered Skin Substitutes Introduction
11.20.4 Promethean LifeSciences Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.20.5 Promethean LifeSciences Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details